Press Releases
February 13, 2026
Anand Kripalu Joins Lupin Board as Independent Director
February 4, 2026
Lupin Launches Topiramate Extended-Release Capsules in the United States
February 2, 2026
Lupin Launches Dasatinib Tablets in the United States
February 2, 2026
Lupin and TB Alliance Join Forces to Advance Telacebec for the Treatment of Tuberculosis and Other Mycobacterial Diseases
January 21, 2026
Lupin and Galenicum Sign License and Supply Agreement for Semaglutide in 23 Countries
December 18, 2025
Lupin Signs Exclusive Licensing Agreement with Neopharmed for Gastroenterology Brand Plasil® in the Philippines and Brazil
December 12, 2025
Lupin Manufacturing Solutions and PolyPeptide Announce Strategic Alliance to Scale Global Peptide Supply Chain
December 5, 2025
Lupin Receives Tentative Approval from U.S. FDA for Siponimod Tablets
December 4, 2025
Lupin and Valorum Enter into an Exclusive Licensing Agreement for Biosimilar Armlupeg™ (Pegfilgrastim-unne) in the United States
Media
Rajalakshmi Azariah
Vice President & Global Head - Corporate Communications
rajalakshmiazariah@lupin.comElise Titan
Director, U.S. Communications
elisetitan@lupin.comSmart Guide
Close
Search Product

Global Privacy Control Detected
We have detected your Global Privacy Control (GPC) signal. In accordance with applicable privacy laws, we have automatically honored your preference and disabled all non-essential cookies and tracking.
Only necessary cookies required for the website to function are enabled.
Opt-Out Request Honored
We have respected your privacy preference. Your opt-out request through cookie settings or Global Privacy Control signal has been honored.
